ArticleFrontiers in oncology2026

Eupatilin-derived compounds enhance antitumor activity and doxorubicin efficacy in triple-negative breast cancer.

Choong-Jae Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.